Risk factor
Very poor trading liquidity
Profitability factor
Weak growth
About
H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts for medical technology, automotive, and other industries. The company also provides petroleum jellies, motor oils, process oils, cable filling compounds, ozone protection waxes, cosmetic and pharmaceutical raw materials, mineral oils, and construction insulation materials. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. The company was founded in 1919 and is headquartered in Salzbergen, Germany. H&R GmbH & Co. KGaA is a subsidiary of H&R Komplementär GmbH.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA, overpri
Target Price
The average target price of 2HRA.DE is 4.3 and suggests 6% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell